Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHRA (Medicines and Healthcare products Regulatory Agency) reviews UK blood pressure monitoring market

This article was originally published in Clinica

Executive Summary

The UK's blood pressure monitoring devices market is facing significant changes, notably to policy of procurement and use. Recommendations for new standards, classification and accreditation of products surrounding the current phasing out of mercury devices were made during the most recent meeting of the Medicines and Healthcare products Regulatory Agency's Committee on Blood Pressure Monitoring in Clinical Practice, held on March 10.

Topics

UsernamePublicRestriction

Register

MT058861

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel